TFF PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
TFF PHARMACEUTICALS, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $58.25 per share as of 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2024-11-20
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $58.25.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $76.61.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $74.63.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $74.63.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2024-09-30 | $58.25 10-Q · filed 2024-11-20 | |
| 2024-06-30 | $76.61 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $74.63 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $74.63 10-Q · filed 2024-11-20 | |
| 2023-09-30 | $3.35 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $162.00 10-K · filed 2024-03-28 | $5.96 10-Q · filed 2023-11-14 |
| 2021-12-31 | $162.00 10-K · filed 2024-03-28 | |
| 2020-12-31 | $2.68 10-K · filed 2021-03-10 | |
| 2019-12-31 | $2.71 10-K · filed 2021-03-10 | |
| 2019-09-30 | $1.56 10-Q · filed 2019-12-09 | |
| 2018-12-31 | $1.56 10-K · filed 2021-03-10 |